Publications by authors named "M Karkucak"

Behçet's syndrome (BS) is a complex, multi-systemic disorder with a global occurrence, notably concentrated along the Silk Road. This study aimed to investigate gender-specific expressions and clinical phenotypes in BS patients within the Eastern Black Sea Region of Turkey. A total of 290 BS patients were retrospectively analyzed between January 2013 and December 2023.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on understanding how common fibromyalgia syndrome (FS) and widespread pain are among patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS), while also examining related clinical and demographic factors.
  • Conducted over 14 centers in Türkiye, the research included 661 patients, differentiating those with FS from those with widespread pain but not meeting FS criteria.
  • Results showed that significant percentages of both RA (34.1% with FS) and AS (29.2% with FS) patients had high polysymptomatic distress (PSD) scores, indicating a high level of discomfort and symptomatology associated with their conditions.
View Article and Find Full Text PDF

Background: Carbonic anhydrases (CA) are metalloenzymes with wide tissue distribution, involved in many important physiological processes, and in some rheumatic diseases, autoantibodies are formed against these enzymes. Recent studies have suggested that oxidative stress triggers anti-CA antibody formation. In this study, we aimed to investigate the effects of modification with oxidative/nitrosative stress end products on CA antigenicity in mice and the relationship between the modified CA autoantibodies and oxidant-antioxidant status in patients with rheumatoid arthritis (RA) and Sjögren's syndrome (SjS).

View Article and Find Full Text PDF

To evaluate of hepatitis serology and reactivation frequency in patients with rheumatic disease receiving biologic agents. Our study included patients with inflammatory rheumatic diseases from 23 centers, who were followed up with biological therapy. Demographic and clinical characteristics of the patients, duration of drug use and hepatitis serology and the state of viral reactivation were analyzed.

View Article and Find Full Text PDF